Pfizer (PFE) Short Interest Ratio & Short Volume → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free PFE Stock Alerts $28.58 -0.22 (-0.76%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pfizer Short Interest DataCurrent Short Interest70,220,000 sharesPrevious Short Interest62,510,000 sharesChange Vs. Previous Month+12.33%Dollar Volume Sold Short$2.02 billionShort Interest Ratio1.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares5,666,590,000 sharesPercentage of Shares Shorted1.24%Today's Trading Volume27,526,201 sharesAverage Trading Volume41,926,352 sharesToday's Volume Vs. Average66% Short Selling Pfizer ? Sign up to receive the latest short interest report for Pfizer and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPFE Short Interest Over TimePFE Days to Cover Over TimePFE Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Pfizer Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202470,220,000 shares $2.02 billion +12.3%N/A1.7 $28.82 4/30/202462,510,000 shares $1.60 billion -8.2%N/A1.5 $25.61 4/15/202468,060,000 shares $1.76 billion +4.7%N/A1.6 $25.90 3/31/202465,000,000 shares $1.80 billion -9.3%N/A1.5 $27.75 3/15/202471,650,000 shares $2.00 billion +8.4%N/A1.7 $27.97 2/29/202466,120,000 shares $1.76 billion +9.0%N/A1.4 $26.55 Get the Latest News and Ratings for PFE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pfizer and its competitors with MarketBeat's FREE daily newsletter. 2/15/202460,680,000 shares $1.67 billion +0.8%N/A1.3 $27.51 1/31/202460,190,000 shares $1.63 billion +4.5%N/A1.3 $27.06 1/15/202457,580,000 shares $1.65 billion +1.0%N/A1.4 $28.70 12/31/202357,030,000 shares $1.64 billion -7.9%N/A1.4 $28.79 12/15/202361,890,000 shares $1.65 billion +8.7%N/A1.6 $26.59 11/30/202356,940,000 shares $1.73 billion -1.0%N/A1.8 $30.44 11/15/202357,500,000 shares $1.74 billion +21.9%N/A2 $30.19 10/31/202347,180,000 shares $1.44 billion -13.5%N/A1.8 $30.56 10/15/202354,570,000 shares $1.75 billion +6.8%N/A2 $32.11 9/30/202351,080,000 shares $1.69 billion +2.3%N/A2.1 $33.17 9/15/202349,950,000 shares $1.70 billion -1.0%N/A2 $34.03 8/31/202350,460,000 shares $1.79 billion -3.7%N/A2.1 $35.38 8/15/202352,390,000 shares $1.85 billion +14.2%N/A1.9 $35.39 7/31/202345,860,000 shares $1.65 billion -13.0%N/A1.7 $36.06 7/15/202352,680,000 shares $1.91 billion -11.5%N/A2 $36.32 6/30/202359,510,000 shares $2.18 billion +8.0%N/A2.3 $36.68 6/15/202355,120,000 shares $2.19 billion -1.2%N/A2.2 $39.77 5/31/202355,780,000 shares $2.12 billion +21.5%N/A2.3 $38.02 5/15/202345,920,000 shares $1.71 billion +4.7%N/A1.9 $37.16 4/30/202343,870,000 shares $1.71 billion +6.0%N/A2.1 $38.89 4/15/202341,370,000 shares $1.70 billion -15.7%N/A1.9 $41.19 3/31/202349,070,000 shares $2.00 billion +11.2%N/A2.1 $40.80 3/15/202344,140,000 shares $1.78 billion +14.7%N/A2 $40.28 2/28/202338,490,000 shares $1.56 billion +1.2%N/A1.7 $40.57 2/15/202338,020,000 shares $1.65 billion -2.9%N/A1.7 $43.32 1/31/202339,170,000 shares $1.73 billion +5.4%N/A1.8 $44.16 1/15/202337,170,000 shares $1.78 billion -12.6%N/A1.7 $47.85 12/30/202242,530,000 shares $2.18 billion -26.7%N/A2 $51.24 12/15/202258,020,000 shares $3.11 billion -7.7%N/A2.7 $53.61 11/30/202262,830,000 shares $3.15 billion -10.3%N/A3.1 $50.13 11/15/202270,040,000 shares $3.40 billion +28.1%N/A3.6 $48.57 10/31/202254,690,000 shares $2.55 billion -12.5%N/A2.7 $46.55 10/15/202262,510,000 shares $2.68 billion +3.5%N/A3.2 $42.86 9/30/202260,370,000 shares $2.64 billion -5.5%N/A3.3 $43.76No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY 9/15/202263,890,000 shares $2.94 billion +2.7%N/A3.6 $45.94 8/31/202262,200,000 shares $2.81 billion -8.5%N/A3.3 $45.23 8/15/202267,940,000 shares $3.38 billion +13.4%N/A3.4 $49.75 7/31/202259,900,000 shares $3.03 billion -11.1%N/A2.9 $50.51 7/15/202267,350,000 shares $3.49 billion -2.3%N/A3 $51.75 6/30/202268,930,000 shares $3.61 billion -10.5%N/A2.9 $52.43 6/15/202276,980,000 shares $3.73 billion -0.3%N/A3.1 $48.51 5/31/202277,200,000 shares $4.09 billion +33.9%N/A2.9 $53.04 5/15/202257,670,000 shares $2.88 billion -15.2%N/A2.1 $49.92 4/30/202267,990,000 shares $3.34 billion +8.5%N/A2.3 $49.07 4/15/202262,650,000 shares $3.33 billion +1.8%N/A2 $53.12 3/31/202261,560,000 shares $3.19 billion +0.6%N/A1.9 $51.77 3/15/202261,180,000 shares $3.19 billion -6.8%N/A1.7 $52.21 2/28/202265,640,000 shares $3.08 billion +3.8%N/A1.7 $46.94 2/15/202263,260,000 shares $3.15 billion -8.6%N/A1.5 $49.79 1/31/202269,220,000 shares $3.65 billion +8.0%N/A1.6 $52.69 1/15/202264,080,000 shares $3.52 billion +9.3%N/A1.5 $54.95 12/31/202158,640,000 shares $3.46 billion -11.2%N/A1.4 $59.05 12/15/202166,010,000 shares $3.88 billion +3.9%N/A1.7 $58.80 11/30/202163,560,000 shares $3.42 billion +0.0%N/A1.9 $53.73 11/15/202163,540,000 shares $3.15 billion +7.9%N/A2.1 $49.65 10/29/202158,880,000 shares $2.58 billion +8.1%N/A1.7 $43.74 10/15/202154,480,000 shares $2.26 billion +4.4%N/A1.7 $41.49 9/30/202152,180,000 shares $2.24 billion -3.5%N/A1.6 $43.01 9/15/202154,090,000 shares $2.42 billion -7.8%N/A1.7 $44.77 8/31/202158,670,000 shares $2.70 billion -4.5%N/A1.9 $46.07 8/13/202161,420,000 shares $2.98 billion +12.7%N/A2.1 $48.48 7/30/202154,500,000 shares $2.33 billion -11.0%1.0%2.1 $42.81 7/15/202161,240,000 shares $2.46 billion -3.0%N/A2.5 $40.09 6/30/202163,150,000 shares $2.47 billion +5.7%N/A2.4 $39.16 6/15/202159,770,000 shares $2.37 billion +1.3%N/A2.2 $39.59 5/28/202159,000,000 shares $2.29 billion +2.9%N/A2.2 $38.73 5/14/202157,320,000 shares $2.30 billion -1.2%N/A2 $40.10 4/30/202158,020,000 shares $2.24 billion -4.7%N/A1.9 $38.60 4/15/202160,890,000 shares $2.26 billion -7.6%N/A1.9 $37.17 3/31/202165,930,000 shares $2.38 billion -3.5%N/A2 $36.11 3/15/202168,320,000 shares $2.39 billion +1.0%N/A2 $34.94 2/26/202167,650,000 shares $2.29 billion +7.2%N/A1.7 $33.82 2/12/202163,120,000 shares $2.17 billion +0.0%N/A1.5 $34.43 1/29/202163,110,000 shares $2.26 billion -3.6%N/A1.3 $35.86 1/15/202165,480,000 shares $2.41 billion +0.3%N/A1.4 $36.75 12/31/202065,270,000 shares $2.40 billion +3.4%N/A1.5 $36.74 12/15/202063,140,000 shares $2.48 billion -0.9%N/A1.5 $39.21 11/30/202063,680,000 shares $2.37 billion -4.3%N/A1.7 $37.23 11/15/202066,530,000 shares $2.57 billion +44.9%N/A2.1 $38.62 10/30/202045,930,000 shares $1.62 billion +13.6%N/A1.7 $35.28 10/15/202040,440,000 shares $1.49 billion -10.5%N/A1.7 $36.86 9/30/202045,160,000 shares $1.66 billion +5.6%N/A1.8 $36.70 9/15/202042,750,000 shares $1.58 billion -5.4%N/A1.6 $36.96 8/31/202045,210,000 shares $1.71 billion -10.0%N/A1.5 $37.79No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY 8/14/202050,220,000 shares $1.91 billion -6.1%N/A1.6 $38.06 7/31/202053,490,000 shares $2.06 billion +12.7%N/A1.7 $38.48 7/15/202047,470,000 shares $1.70 billion -7.8%N/A1.6 $35.72 6/30/202051,490,000 shares $1.68 billion -4.2%N/A1.8 $32.70 6/15/202053,750,000 shares $1.79 billion +3.3%N/A1.9 $33.36 5/29/202052,040,000 shares $1.99 billion -1.1%N/A1.7 $38.19 5/15/202052,590,000 shares $1.99 billion +7.4%N/A1.7 $37.76 4/30/202048,960,000 shares $1.88 billion +10.5%N/A1.5 $38.36 4/15/202044,310,000 shares $1.59 billion -4.6%0.8%1.3 $35.97 3/31/202046,450,000 shares $1.74 billion -21.4%0.8%1.4 $37.38 3/13/202059,077,400 shares $2.09 billion +10.1%1.1%2.3 $35.39 2/28/202053,670,000 shares $1.53 billion -8.5%1.0%2.1 $28.49 2/14/202058,670,000 shares $2.03 billion -3.9%1.1%2.6 $34.59 1/31/202061,030,000 shares $2.12 billion +7.1%1.1%2.9 $34.72 1/15/202056,970,000 shares $2.17 billion -0.3%1.0%2.9 $38.09 12/31/201957,140,000 shares $2.28 billion -2.9%1.0%3.1 $39.82 PFE Short Interest - Frequently Asked Questions What is Pfizer's current short interest? Short interest is the volume of Pfizer shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 70,220,000 shares of PFE short. Learn More on Pfizer's current short interest. What is a good short interest ratio for Pfizer? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PFE shares currently have a short interest ratio of 2.0. Learn More on Pfizer's short interest ratio. Which institutional investors are shorting Pfizer? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: Walleye Trading LLC, Jane Street Group LLC, CMT Capital Markets Trading GmbH, BlueCrest Capital Management Ltd, Capital Markets Trading UK LLP, Torno Capital LLC, PEAK6 Investments LLC, National Bank of Canada FI, HAP Trading LLC, JPMorgan Chase & Co., XR Securities LLC, SG Americas Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Caas Capital Management LP, Oak Hill Wealth Advisors LLC, Simplex Trading LLC, IMC Chicago LLC, Curated Wealth Partners LLC, Private Capital Management LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pfizer's short interest increasing or decreasing? Pfizer saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 70,220,000 shares, an increase of 12.3% from the previous total of 62,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pfizer's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pfizer: Johnson & Johnson (0.73%), Merck & Co., Inc. (0.80%), AbbVie Inc. (0.91%), Bristol-Myers Squibb (1.39%), Zoetis Inc. (1.32%), Royalty Pharma plc (3.47%), Jazz Pharmaceuticals plc (5.20%), Perrigo Company plc (3.08%), Corcept Therapeutics Incorporated (22.07%), Supernus Pharmaceuticals, Inc. (9.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Pfizer stock? Short selling PFE is an investing strategy that aims to generate trading profit from Pfizer as its price is falling. PFE shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pfizer? A short squeeze for Pfizer occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PFE, which in turn drives the price of the stock up even further. How often is Pfizer's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JNJ Short Squeeze MRK Short Squeeze ABBV Short Squeeze BMY Short Squeeze ZTS Short Squeeze RPRX Short Squeeze JAZZ Short Squeeze PRGO Short Squeeze CORT Short Squeeze SUPN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:PFE) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.